Researchers have found that gradually depleting an enzyme called BACE1 completely reverses the formation of amyloid plaques in the brains of mice with Alzheimer's disease, thereby improving the animals' cognitive function. The study raises hopes that drugs targeting this enzyme will be able to successfully treat Alzheimer's disease in humans.
